Enhancing Cancer Care with Personalised Support
5
th
June 2019
Catherine Neck, Macmillan Cancer Rehabilitation/ LWBC Lead
On behalf of SWAG Alliance
1
L
i
v
i
n
g
W
i
t
h
&
B
e
y
o
n
d
C
a
n
c
e
r
(
P
e
r
s
o
n
a
l
i
s
e
d
C
a
r
e
)
:
S
W
A
G
C
o
l
o
r
e
c
t
a
l
C
A
G
U
p
d
a
t
e
By 2021, where appropriate every person diagnosed with
cancer will have access to personalised care, including needs
assessment, a care plan and health and wellbeing
information and support.
After treatment, patients will move to a follow-up pathway that
suits their needs, and ensures they can get rapid access to
clinical support where they are worried that their cancer may
have recurred.
T
h
i
s
s
t
r
a
t
i
f
i
e
d
f
o
l
l
o
w
-
u
p
a
p
p
r
o
a
c
h
w
i
l
l
b
e
e
s
t
a
b
l
i
s
h
e
d
i
n
a
l
l
t
r
u
s
t
s
f
o
r
b
r
e
a
s
t
c
a
n
c
e
r
i
n
2
0
1
9
,
f
o
r
p
r
o
s
t
a
t
e
a
n
d
c
o
l
o
r
e
c
t
a
l
c
a
n
c
e
r
s
i
n
2
0
2
0
2
N
H
S
L
o
n
g
T
e
r
m
P
l
a
n
From April 2020:
•
All breast, colorectal and prostate cancer patients from
diagnosis (including secondary cancer) to have access to
personalised support
•
Approximately two-thirds of patients who finish treatment
for breast cancer to be on a supported self-management
follow-up pathway and from diagnosis
•
All Alliance Trusts to have in place protocols for stratifying
the follow up of prostate and colorectal patients and
systems for remote monitoring for these patients and from
diagnosis
3
N
H
S
E
r
e
q
u
i
r
e
m
e
n
t
s
f
o
r
P
e
r
s
o
n
a
l
i
s
e
d
C
a
r
e
•
Introduce remote monitoring systems for breast,
prostate and colorectal
•
Support commissioners with evaluation to inform an
options appraisal, which will support decision on the
future delivery of personalised care and support
across the Alliance
•
Continue collection of metrics that demonstrate
patient experience and number of patients covered
4
S
W
A
G
L
W
B
C
I
m
p
l
e
m
e
n
t
a
t
i
o
n
2
0
1
9
/
2
0
•
We will be funding the set-up costs of remote
monitoring systems from Alliance funds in 2019/20
(perhaps My Medical Record)
•
We had thought that we might use some of our
Alliance funding for 2019/20 to support CCGs to
embed personalised care in recurrent funding – but
both regional and National team were uncomfortable
with this approach.
•
The risk to sustainability of the LWBC programme has
been raised with national team and discussions are
ongoing.
5
R
e
m
o
t
e
M
o
n
i
t
o
r
i
n
g
&
O
n
g
o
i
n
g
S
u
s
t
a
i
n
a
b
i
l
i
t
y
f
o
r
L
W
B
C
At end of treatment all patients to receive a CNS review which includes the following:
•
H
o
l
i
s
t
i
c
N
e
e
d
s
A
s
s
e
s
s
m
e
n
t
a
n
d
C
a
r
e
P
l
a
n
•
B
o
o
k
i
n
g
o
n
t
o
a
H
e
a
l
t
h
&
W
e
l
l
b
e
i
n
g
C
l
i
n
i
c
.
I
f
p
a
t
i
e
n
t
h
a
s
a
l
r
e
a
d
y
a
t
t
e
n
d
e
d
a
n
e
a
r
l
y
H
&
W
B
c
l
i
n
i
c
t
h
e
n
t
o
b
e
g
i
v
e
n
s
i
t
e
s
p
e
c
i
f
i
c
a
d
v
i
c
e
a
b
o
u
t
s
i
g
n
s
a
n
d
s
y
m
p
t
o
m
s
o
f
r
e
c
u
r
r
e
n
c
e
a
n
d
p
o
s
s
i
b
l
e
l
a
t
e
e
f
f
e
c
t
s
o
f
t
r
e
a
t
m
e
n
t
•
C
o
m
p
l
e
t
i
o
n
o
f
T
r
e
a
t
m
e
n
t
S
u
m
m
a
r
y
Patients are then stratified into one of the following follow-up pathways. N.B. Patients
should be reassessed and move freely between follow up pathways as their
condition or needs change:
•
S
u
p
p
o
r
t
e
d
s
e
l
f
-
m
a
n
a
g
e
m
e
n
t
p
a
t
h
w
a
y
w
i
t
h
r
o
u
t
i
n
e
s
u
r
v
e
i
l
l
a
n
c
e
a
n
d
o
p
e
n
a
c
c
e
s
s
•
S
h
a
r
e
d
C
a
r
e
•
C
o
m
p
l
e
x
c
a
s
e
m
a
n
a
g
e
m
e
n
t
•
D
i
s
c
h
a
r
g
e
d
t
o
G
P
c
a
r
e
6
S
W
A
G
C
o
l
o
r
e
c
t
a
l
S
t
r
a
t
i
f
i
e
d
P
a
t
h
w
a
y
•
Patients who are able to understand and engage with
process
•
No active disease/ serious/ uncontrolled symptoms
from treatment
•
Can be for all stages of colorectal cancer (primary)
•
All bloods, CTs, colonoscopies undertaken as per
protocol
7
S
e
l
f
-
M
a
n
a
g
e
m
e
n
t
w
i
t
h
O
p
e
n
A
c
c
e
s
s
:
•
Patients requiring physical examination
•
Nurse-led clinic for those unable to engage with self-
management pathway i.e. due to cognitive or
psychological issues
•
Trials Patients (should be on a pathway that
meets stipulations in trial protocol)
8
S
h
a
r
e
d
C
a
r
e
:
•
Serious uncontrolled symptoms
•
Complex management or intense surveillance
required i.e. following metastatic resections or T1
polypectomy’s
•
Palliative patients receiving treatment
•
Trials patients (or on shared care pathway)
9
C
o
m
p
l
e
x
M
a
n
a
g
e
m
e
n
t
v
i
a
M
D
T
:
•
Very frail patients
•
Patients for who no further active treatment would be
offered
•
Not requiring further scans or blood tests
10
D
i
s
c
h
a
r
g
e
t
o
G
P
:
N
o
r
m
a
l
R
e
s
u
l
t
s
:
•
Results reviewed and patient informed via letter
•
Holistic Needs Assessment (paper copy and
electronic link) sent with CT results at 1 and 2 years
•
Patient informed to make contact if help is needed
and given reminder of next test date
•
Reminder of signs and symptoms given to patient
11
S
e
l
f
-
m
a
n
a
g
e
m
e
n
t
p
a
t
h
w
a
y
p
r
o
c
e
s
s
A
b
n
o
r
m
a
l
R
e
s
u
l
t
s
/
C
o
n
c
e
r
n
s
/
S
y
m
p
t
o
m
s
:
•
Open access into system within 2 weeks
•
Further diagnostic tests as required
•
MDT review
•
OPA
12
S
e
l
f
-
m
a
n
a
g
e
m
e
n
t
p
a
t
h
w
a
y
p
r
o
c
e
s
s
•
Need to understand current position of teams against
this pathway
•
What steps are needed to move towards delivery of
this pathway?
13
D
i
s
c
u
s
s
i
o
n
/
N
e
x
t
S
t
e
p
s
:
The NHS Long Term Plan aims to provide personalised care for cancer patients, including tailored follow-up pathways and remote monitoring systems. Implementation strategies and funding considerations are highlighted for sustainable support.
Download Presentation
Please find below an Image/Link to download the presentation.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.
You are allowed to download the files provided on this website for personal or commercial use, subject to the condition that they are used lawfully. All files are the property of their respective owners.
The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author.
E N D
Presentation Transcript
Living With & Beyond Cancer (Personalised Care): SWAG Colorectal CAG Update 5thJune 2019 Catherine Neck, Macmillan Cancer Rehabilitation/ LWBC Lead On behalf of SWAG Alliance www.england.nhs.uk 1
NHS Long Term Plan By 2021, where appropriate every person diagnosed with cancer will have access to personalised care, including needs assessment, a care plan and health and wellbeing information and support. After treatment, patients will move to a follow-up pathway that suits their needs, and ensures they can get rapid access to clinical support where they are worried that their cancer may have recurred. This stratified follow-up approach will be established in all trusts for breast cancer in 2019, for prostate and colorectal cancers in 2020 www.england.nhs.uk 2
NHSE requirements for Personalised Care From April 2020: All breast, colorectal and prostate cancer patients from diagnosis (including secondary cancer) to have access to personalised support Approximately two-thirds of patients who finish treatment for breast cancer to be on a supported self-management follow-up pathway and from diagnosis All Alliance Trusts to have in place protocols for stratifying the follow up of prostate and colorectal patients and systems for remote monitoring for these patients and from diagnosis www.england.nhs.uk 3
SWAG LWBC Implementation 2019/20 Introduce remote monitoring systems for breast, prostate and colorectal Support commissioners with evaluation to inform an options appraisal, which will support decision on the future delivery of personalised care and support across the Alliance Continue collection of metrics that demonstrate patient experience and number of patients covered www.england.nhs.uk 4
Remote Monitoring & Ongoing Sustainability for LWBC We will be funding the set-up costs of remote monitoring systems from Alliance funds in 2019/20 (perhaps My Medical Record) We had thought that we might use some of our Alliance funding for 2019/20 to support CCGs to embed personalised care in recurrent funding but both regional and National team were uncomfortable with this approach. The risk to sustainability of the LWBC programme has been raised with national team and discussions are ongoing. www.england.nhs.uk 5
SWAG Colorectal Stratified Pathway At end of treatment all patients to receive a CNS review which includes the following: Holistic Needs Assessment and Care Plan Booking onto a Health & Wellbeing Clinic. If patient has already attended an early H&WB clinic then to be given site specific advice about signs and symptoms of recurrence and possible late effects of treatment Completion of Treatment Summary Patients are then stratified into one of the following follow-up pathways. N.B. Patients should be reassessed and move freely between follow up pathways as their condition or needs change: Supported self-management pathway with routine surveillance and open access Shared Care Complex case management Discharged to GP care www.england.nhs.uk 6
Self-Management with Open Access: Patients who are able to understand and engage with process No active disease/ serious/ uncontrolled symptoms from treatment Can be for all stages of colorectal cancer (primary) All bloods, CTs, colonoscopies undertaken as per protocol www.england.nhs.uk 7
Shared Care: Patients requiring physical examination Nurse-led clinic for those unable to engage with self- management pathway i.e. due to cognitive or psychological issues Trials Patients (should be on a pathway that meets stipulations in trial protocol) www.england.nhs.uk 8
Complex Management via MDT: Serious uncontrolled symptoms Complex management or intense surveillance required i.e. following metastatic resections or T1 polypectomy s Palliative patients receiving treatment Trials patients (or on shared care pathway) www.england.nhs.uk 9
Discharge to GP: Very frail patients Patients for who no further active treatment would be offered Not requiring further scans or blood tests www.england.nhs.uk 10
Self-management pathway process Normal Results: Results reviewed and patient informed via letter Holistic Needs Assessment (paper copy and electronic link) sent with CT results at 1 and 2 years Patient informed to make contact if help is needed and given reminder of next test date Reminder of signs and symptoms given to patient www.england.nhs.uk 11
Self-management pathway process Abnormal Results / Concerns / Symptoms: Open access into system within 2 weeks Further diagnostic tests as required MDT review OPA www.england.nhs.uk 12
Discussion/ Next Steps: Need to understand current position of teams against this pathway What steps are needed to move towards delivery of this pathway? www.england.nhs.uk 13
